Daybue 200 mg/mL oral solution Images
Generic Name: trofinetide
This medication has been identified as Daybue 200 mg/mL oral solution. It is supplied by Acadia Pharmaceuticals Inc.
Daybue is used in the treatment of Rett Syndrome and belongs to the drug class miscellaneous central nervous system agents. Daybue 200 mg/mL oral solution is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Daybue
- Generic Name
- trofinetide
- Strength
- 200 mg/mL oral solution
- Availability
- Prescription only
- Drug Class
- Miscellaneous central nervous system agents
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Acadia Pharmaceuticals Inc.
- National Drug Code (NDC)
- 63090-0660
More about Daybue (trofinetide)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous central nervous system agents
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
